Trials / Completed
CompletedNCT05140213
A STUDY BEFORE/AFTER THE IMPLEMENTATION OF AN ANTI-INFECTIOUS PRESCRIPTION AID
EVALUATION OF 30-DAY MORTALITY AFTER A VISIT TO THE LAPEYRONIE ADULT EMERGENCY DEPARTMENT OF THE CHU MONTPELLIER FOR SEPSIS OR SEPTIC SHOCK
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 371 (actual)
- Sponsor
- University Hospital, Montpellier · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Anti-infective strategy is a major public health problem. This is a before-and-after study of an anti-infectious prescription tool with a comparison of mortality at 30 days (then 3 and 6 months) between the two inclusion phases of 6 months each.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Anti-infectious prescription support tool | implementation of a pocket notebook with current anti-infectious recommendations in the emergency department Patients were kept under surveillance for at least one hour before discharge. Patients were discharged home with a 7 day supply of acetaminophen 1000 mg orally every 6 h, ketoprofen 100 mg, orally twice a day, and muscle relaxant as needed. Patients were instructed to take tramadol 50 mg, orally every 6h as needed for low back pain, in case of insufficient relief. |
Timeline
- Start date
- 2020-12-12
- Primary completion
- 2021-08-12
- Completion
- 2021-08-30
- First posted
- 2021-12-01
- Last updated
- 2021-12-23
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05140213. Inclusion in this directory is not an endorsement.